Pharmaceutical firm Immunomedics reported 2003 fiscal first-quarter revenues of $3.2 million, down slightly from the $3.3 million reported last year. For the period (end-September 30), the Morris Plains, NJ-based vendor had a net loss of $2.9 million, compared with a net loss of $182,000 reported in the 2002 fiscal first quarter. Immunomedics said that the increased loss was due to a corporate expansion, including hiring of additional oncologists, and the growth of its R&D capabilities.
By AuntMinnie.com staff writersNovember 12, 2002
Related Reading
Immunomedics touts breast cancer therapy gains, June 20, 2002
Immunomedics signs South American distributor, May 17, 2002
Immunomedics eyes Australia for LeukoScan, March 7, 2002
Immunomedics doubles revenue, trims loss, November 9, 2001
Immunomedics licenses labeling method, October 29, 2001
Copyright © 2002 AuntMinnie.com
